IWM News 113.03 07/29/2014 05:22:02 Russell 2000 ETF (IWM)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Russell 2000 ETF (IWM) 113.03 $IWM

Stock Market Today: Small Gains For U.S. Stocks as Mergers Overshadow Global Anxieties
at The Street - Mon Jul 28, 3:18PM CDT
U.S. stock indices recoup losses sustained earlier in the day as merger news outweighs weaker-than-expected housing data and stricter Russia sanctions from the U.S. and European Union in coming days.

Stock Market Today: U.S. Stocks Trade Sideways; Trulia Surges; Key Data Loom
at The Street - Mon Jul 28, 9:14AM CDT
Benchmark U.S. stock indices open little changed Monday awaiting this week's Federal Reserve policy announcement on Wednesday, July government jobs report on Friday and second-quarter GDP figures on Wednesday.

Stock Market Today: Futures Little Changed Ahead of Data Barrage
at The Street - Mon Jul 28, 7:12AM CDT
Stock futures are little changed Monday awaiting this week's Federal Reserve policy announcement on Wednesday, July government jobs report on Friday and second-quarter GDP figures on Wednesday.

Emerging Markets Outperform U.S. Equities Thanks to Latin America, China
at The Street - Wed Jul 23, 10:33AM CDT
Strong growth in China and Brazil overcome weakness in Russia.

Regional Bank Index Not Optimistic - Real Time Insight
Kevin Cook - ZACKS - Tue Jul 22, 3:28PM CDT
Is the KRE weakness more about the economy or the yield curve?

Safe Haven ETFs to Evade Geopolitical Tensions - ETF News And Commentary
Sweta Killa - ZACKS - Tue Jul 22, 2:00PM CDT
The uncertainty in Ukraine and the Middle East compelled investors to shift their focus to safe haven ETF plays.

How to Use Just 4 iShares ETFs to Invest Simply and Effectively
Dan Caplinger, The Motley Fool - Motley Fool - Sun Jul 20, 9:05AM CDT
Investing doesn't have to be difficult. Exchange-traded funds let you invest simply but effectively with just a few different pieces to your portfolio. In the following video, Dan Caplinger, The Motley Fool's director of investment planning, looks...

'Fast Money' Recap: Fear Gauge Retreats but Be Cautious
at The Street - Sat Jul 19, 4:00AM CDT
The trading panel discussed Friday's rally and what they'll be buying and selling next week.

'Fast Money' Recap: Trading on Geopolitical Tensions
at The Street - Fri Jul 18, 4:00AM CDT
The trading panel discussed the downing of a Malaysian airliner over Ukraine, Israel's ground war in Gaza and whether to invest in Google and IBM.

iShares Russell 2000 Index Fund Falls 1.54% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Thu Jul 17, 4:05PM CDT
iShares Russell 2000 Index Fund (AMEX:IWM) traded in a range yesterday that spanned from a low of $112.20 to a high of $114.27. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $113.82 on volume of 61.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Watch for iShares Russell 2000 Index Fund to Potentially Rebound After Falling 1.54% Yesterday
Comtex SmarTrend(R) - Thu Jul 17, 4:04PM CDT
iShares Russell 2000 Index Fund (AMEX:IWM) traded in a range yesterday that spanned from a low of $112.20 to a high of $114.27. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $113.82 on volume of 61.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

The Fed's Valuation Concerns Put These Growth ETFs in Focus - ETF News And Commentary
Zacks Equity Research - ZACKS - Thu Jul 17, 9:00AM CDT
Thanks to Yellen and her comments, these high growth ETFs could be in focus.

Yellen, Icahn Comments Put a Lid on Small-Cap Stocks, May Hurt Larger Market
at The Street - Wed Jul 16, 10:40AM CDT
Recent comments by Fed Chair Janet Yellen and activist investor Carl Icahn have led to selling pressure in small-cap stocks.

Stock Pickers' Market Coming Off Oversold Reading for S&P 500
at The Street - Mon Jul 14, 3:51PM CDT
We are coming off oversold levels, so who know if this is a bounce or something more sustainable.

Dangerously Askew - Real Time Insight
Kevin Cook - Zacks Investment Research - Mon Jul 14, 9:35AM CDT
This stealth measure of put option buying warns before the VIX

'Fast Money' Recap: Is Gold's Rally For Real?
at The Street - Mon Jul 14, 4:00AM CDT
The trading panel looks at gold to distinguish if the recent gains are a technical breakout or just a bear market rally.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 78

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 501

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 15

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 45

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 31

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 55

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading

Top 5 Most Recently Viewed Articles

Eco Wave Power Expands Wave Energy Project in Europe

Updated Category News Views 229

Eco Wave Power Initiates Key Infrastructure Enhancements Eco Wave Power Global AB (publ) (NASDAQ: WAVE) is excited to unveil plans for crucial upgrades at its groundbreaking wave energy project. This groundbreaking initiative is set to harness ocean wave energy to produce clean electricity efficiently. Eco Wave Power, recognized as a leading company in onshore wave energy...

Continue Reading
Key Managerial Transactions Reported by Danske Bank A/S

Updated Category News Views 162

Recent Mandatory Transaction Notifications by Danske Bank A/S Danske Bank A/S is committed to transparency in financial transactions involving its managerial personnel. This communication signifies the bank's adherence to the EU Market Abuse Regulation and the requirements set by the Danish Financial Supervisory Authority (FSA) and Nasdaq Copenhagen. Understanding...

Continue Reading
Strategic Insights into Symbotic's Options Market Activity

Updated Category News Views 187

Overview of Options Activity for Symbotic Recently, significant investors have demonstrated a notably bearish outlook on Symbotic. This trend has been evidenced by the options activity surrounding the company's stock, symbolized by SYM. The strong presence of whales entering the market indicates a shift in investor sentiment, with nuances that are crucial for...

Continue Reading
South Coast AQMD Takes Action on Oil Facilities During Violations

Updated Category News Views 267

South Coast AQMD Addresses Oil Site Violations In a determined effort to safeguard public health and air quality, the South Coast Air Quality Management District (South Coast AQMD) has recently taken enforcement action against three oil and gas facilities in Los Angeles. These actions were prompted by public complaints and confirmed violations of air quality regulations,...

Continue Reading
BAM UK & Ireland and LoadSpring Solutions Innovate Project Management

Updated Category News Views 199

BAM UK & Ireland and LoadSpring Solutions Innovate Project Management BAM UK & Ireland, a prominent name in the construction and engineering sector, has taken a bold step forward by partnering with LoadSpring Solutions. This collaboration aims to revolutionize project management through an innovative solution known as LoadSpring INSIGHTS™. This groundbreaking platform...

Continue Reading